Long-term Resolution of Comorbidites After Gastric Bypass
Long-term Resolution of Comorbidites After Gastric Bypass
To evaluate effect on comorbid disease and weight loss in the long-term (>five years) after Roux-en-Y gastric bypass (RYGB) surgery for severe obesity.
Individuals with severe obesity frequently have comorbid diseases, e.g. diabetes, hypertension, hyperlipidemia, and sleep apnea. We will study the remission rate and weight loss in the long-term (10 years) after Roux-en-Y gastric bypass (RYGB) surgery in a nationwide large group of patients.
Inclusion Criteria:
Exclusion Criteria:
erik.naslund@ki.se
magnus.sundbom@surgsci.uu.se